Artal Group S.A. - ITEOS THERAPEUTICS INC ownership

ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 160 filers reported holding ITEOS THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 6.56 and the average weighting 0.5%.

Quarter-by-quarter ownership
Artal Group S.A. ownership history of ITEOS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$4,380
-17.3%
400,0000.0%0.19%
+14.6%
Q2 2023$5,296
-2.7%
400,0000.0%0.16%
-49.2%
Q1 2023$5,444
-30.3%
400,0000.0%0.32%
-25.9%
Q4 2022$7,812
-99.9%
400,0000.0%0.44%
+34.2%
Q3 2022$7,620,000
-7.5%
400,0000.0%0.32%
-26.1%
Q2 2022$8,240,000
-36.0%
400,0000.0%0.44%
-18.4%
Q1 2022$12,872,000
-49.2%
400,000
-26.5%
0.54%
-21.5%
Q4 2021$25,331,000
-5.6%
544,047
-45.3%
0.69%
+14.3%
Q3 2021$26,839,000
+5.3%
994,0470.0%0.60%
+16.2%
Q2 2021$25,497,000
-31.8%
994,047
-9.1%
0.52%
-21.8%
Q1 2021$37,395,000
+1.1%
1,094,0470.0%0.66%
-16.8%
Q4 2020$37,001,000
+37.1%
1,094,0470.0%0.79%
+21.2%
Q3 2020$26,990,0001,094,0470.66%
Other shareholders
ITEOS THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 2,738,785$37,274,86415.53%
MPM BioImpact LLC 1,745,943$23,762,2846.17%
Saturn V Capital Management LP 480,653$6,541,6874.89%
Boxer Capital, LLC 2,154,058$29,3171.44%
RA Capital Management 4,417,259$60,118,8951.36%
Octagon Capital Advisors LP 596,000$8,111,5601.17%
BVF INC/IL 1,810,835$24,645,4640.90%
AlphaCentric Advisors LLC 63,000$857,4300.59%
Integral Health Asset Management, LLC 180,000$2,449,8000.49%
683 Capital Management, LLC 480,000$6,532,8000.49%
View complete list of ITEOS THERAPEUTICS INC shareholders